Back to the full story2 sources · STAT+: Pharmalittle: We’re reading about Medicaid obesity-drug coverage, a Regenxbio gene therapy, and more◆ Timeline
STAT+: Pharmalittle: We’re reading about Medicaid obesity-drug coverage, a Regenxbio gene therapy, and more
3 reports in the order each was filed. Tap any entry to open that report at its source.
- 01Fierce BiotechAug 24, 11:51 AMRegenxbio gene therapy refiling plan derailed by FDA hold over spine MRI findings
- 02STATAug 24, 11:59 AMSTAT+: FDA pauses Regenxbio gene therapy trial again due to safety concerns
- 03STATAug 24, 1:36 PMSTAT+: Pharmalittle: We’re reading about Medicaid obesity-drug coverage, a Regenxbio gene therapy, and more